Cargando…
Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei
OBJECTIVES: Pseudomyxoma peritonei (PMP) is a rare cancer currently affecting over 11,736 patients across Europe. Since PMP is so uncommon, collaboration between scientific centers is key to discovering the mechanisms behind the disease, efficient treatments, and targets pointing to a cure. To date,...
Autores principales: | Patrick-Brown, Thale D.J.H., Mohamed, Faheez, Thrower, Andrew, Torgunrud, Annette, Cosyns, Sarah, Canbay, Emel, Villeneuve, Laurent, Flatmark, Kjersti, Brandl, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067554/ https://www.ncbi.nlm.nih.gov/pubmed/37020469 http://dx.doi.org/10.1515/pp-2022-0200 |
Ejemplares similares
-
Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
por: Patrick-Brown, Thale Dawn J. H., et al.
Publicado: (2020) -
ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
por: Flatmark, Kjersti, et al.
Publicado: (2020) -
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
por: Flatmark, Kjersti, et al.
Publicado: (2021) -
Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009) -
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
por: Andersson, Yvonne, et al.
Publicado: (2021)